Skip to main content

ACI's 4th Annual Summit on Life Sciences IP Due Diligence

American Conference Institute (ACI) is hosting its 4th Annual Summit on Life Sciences IP Due Diligence on November 9-10, 2020 in Boston, MA. The conference is devoted to providing life sciences/legal professionals with expert strategies for assessing, valuing and commercializing IP assets when conducting strategic IP due diligence. On November 9, GT Shareholder David Dykeman (BOS) will moderate the session, "Unique Considerations When Conducting IP Due Diligence on Deals Involving Medical Devices (MedTech) and Artificial Intelligence in the Life Sciences."